CDK1 and neoplasm: In vitro cytotoxicity experiments showed that PTX-PTE NPs exhibited enhanced cytotoxicity against both A549 and its drug-resistant strain A549/T cells, which may be related to the downregulation of P-gp and CDK1 expression, demonstrating the potential of PTX-PTE NPs in addressing PTX-resistant tumor cells.